Skip to content

Company

Aurobindo Pharma

India

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Aurobindo Pharma?

Held by 61 covered funds. Sorted by Aurobindo Pharma’s share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
UEVMVictoryShares Emerging Markets Value Momentum0.9%
INDAiShares MSCI India0.3%
AEMZXAcadian Emerging Markets Portfolio0.3%
EPIWisdomTree India Earnings Fund0.3%
FLINFranklin FTSE India0.3%
EMMFWisdomTree Emerging Markets Multifactor Fund0.2%
SEEMSEI Select Emerging Markets Equity0.2%
INDXtrackers Nifty 500 India0.2%
EVLUiShares MSCI Emerging Markets Value Factor0.2%
DFEVDimensional Emerging Markets Value0.1%
GEMGoldman Sachs ActiveBeta(R) Emerging Markets Equity0.1%
XCWisdomTree True Emerging Markets Fund0.1%
XCEMColumbia EM Core ex-China0.1%
KEMXKraneShares MSCI Emerging Markets ex China Index0.1%
GMFSPDR S&P Emerging Asia Pacific0.1%
FEMRFidelity Enhanced Emerging Markets0.1%
JPEMJPMorgan Diversified Return Emerging Markets Equity0.1%
BKFiShares MSCI Bic0.1%
SPEMSPDR Portfolio Emerging Markets0.1%
DEXCDimensional Emerging Markets ex China Core Equity0.1%
AVSEAvantis Responsible Emerging Markets Equity0.1%
AVESAvantis Emerging Markets Value0.1%
NTSEWisdomTree Emerging Markets Efficient Core Fund0.1%
EMCRXtrackers Emerging Markets Carbon Reduction and Climate Improvers0.1%
XCNYSPDR S&P Emerging Markets ex-China0.1%
VEXCVanguard Emerging Markets Ex-China0.1%
AVXCAvantis Emerging Markets ex-China Equity0.1%
JHEMJohn Hancock Multifactor Emerging Markets0.0%
AVEMAvantis Emerging Markets Equity0.0%
EEMAiShares MSCI Emerging Markets Asia0.0%
SCHESchwab Emerging Markets Equity0.0%
XSOEWisdomTree Emerging Markets ex-State-Owned Enterprises Fund0.0%
BBEMJPMorgan BetaBuilders Emerging Markets Equity0.0%
DFAEDimensional Emerging Core Equity Market0.0%
DFEMDimensional Emerging Markets Core Equity 20.0%
AVENXAvantis Emerging Markets Equity Fund0.0%
EMXCiShares MSCI Emerging Markets Ex China0.0%
AAXJiShares MSCI All Country Asia ex Japan0.0%
FLAXFranklin FTSE Asia ex Japan0.0%
GSEEGoldman Sachs MarketBeta Emerging Markets Equity0.0%
EEMXSPDR MSCI Emerging Markets Fossil Fuel Reserves Free0.0%
VWOVanguard Emerging Markets Stock Index Fund0.0%
BKEMBNY Mellon Emerging Markets Equity0.0%
SSKEXState Street Emerging Markets Equity Index Fund0.0%
DBEMXtrackers MSCI Emerging Markets Hedged Equity0.0%
EEMiShares MSCI Emerging Markets0.0%
IEMGiShares Core MSCI Emerging Markets0.0%
CWISPDR MSCI Acwi Ex-US0.0%
DFAXDimensional World ex U.S. Core Equity 20.0%
TLTEFlexShares Morningstar Emerging Markets Factor Tilt Index Fund0.0%
SSGVXState Street Global All Cap Equity ex-U.S. Index Portfolio0.0%
ACWXiShares MSCI ACWI ex U.S.0.0%
VSGXVanguard ESG International Stock0.0%
GXUSGoldman Sachs MarketBeta Total International Equity0.0%
IXUSiShares Core MSCI Total International Stock0.0%
TEMUXEmerging Markets Equity Fund0.0%
VXUSVanguard Total International Stock Index Fund0.0%
VEUVanguard FTSE All-World Ex-US Index Fund0.0%
DBAWXtrackers MSCI All World ex US Hedged Equity0.0%
ACWIiShares MSCI ACWI0.0%
VTVanguard Total World Stock Index Fund0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Aurobindo Pharma news

No recent stories about Aurobindo Pharma.